Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-24

Clinical Trial Update: Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating neurocognitive habilitation for children with fetal alcohol syndrome and alcohol-related neurodevelopmental disorder has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Fetal Alcohol Syndrome, Alcohol-related Neurodevelopmental Disorder | Phase 1, Phase 2 | Status: COMPLETED